Overview

Local Thrombolytics Before Thrombectomy in STEMI

Status:
Enrolling by invitation
Trial end date:
2021-03-01
Target enrollment:
0
Participant gender:
All
Summary
Background Prompt reperfusion with percutaneous coronary intervention (PCI) in the setting of ST-elevation myocardial infarction (STEMI) improves clinical outcomes through salvage of myocardial tissue. Although the use of thrombus aspiration with PCI can result in improved rates of normal epicardial flow and myocardial perfusion, several unmet needs remain. Purpose The purpose of this trial will be to evaluate the hypothesis that local delivery of thrombolytics vs. saline infusion prior to thrombus aspiration and PCI is safe and effective in patients with STEMI.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Roma La Sapienza
Treatments:
Coal Tar
Fibrinolytic Agents
Criteria
Inclusion Criteria:

- ST-elevation myocardial infarction

- angiographic evidence of massive thrombosis in the culprit artery

- Indication to manual thrombectomy followed by primary percutaneous coronary
intervention (PCI)

- Able to understand and willing to sign the informed CF

Exclusion Criteria:

- Women of child bearing potential patients must demonstrate a negative pregnancy test
performed within 24 hours before CT